Cited by 111Glaucoma and retinal disordersNeurological Disorders and TreatmentsNerve injury and regeneration

Neuroprotection in Glaucoma: Animal Models and Clinical Trials

Open access
Almasieh, Mohammadali, Levin, Leonard A.·2017·Annual Review of Vision Science

Abstract

Glaucoma is a progressive neurodegenerative disease that frequently results in irreversible blindness. Glaucoma causes death of retinal ganglion cells (RGCs) and their axons in the optic nerve, resulting in visual field deficits and eventual loss of visual acuity. Glaucoma is a complex optic neuropathy, and a successful strategy for its treatment requires not only better management of known risk factors such as elevated intraocular pressure and the development of improved tools for detecting RGC injury but also treatments that address this injury (i.e., neuroprotection). Experimental models of glaucoma provide insight into the cellular and molecular mechanisms of glaucomatous optic neuropathy and aid the development of neuroprotective therapies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1146/annurev-vision-102016-061422

Cites

185 of 185 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • This is the first example of vision loss reversal after glaucomatous injury has occurred.

    “To our knowledge, this is the first example of vision loss reversal after glaucomatous injury has occurred, with previous attempts focusing on neuroprotection delivered at an early stage to prevent further disease progression41,42 (Supplementary discussion).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Cioffi GA. 2005. Ischemic model of optic nerve injury. Trans. Am. Ophthalmol. Soc. 103:592-613

Cited by

Sorted by citations

Authors
Almasieh, M., & Levin, L. A.
Affiliations
  • Hôpital Maisonneuve-Rosemont (CA)
  • University of Wisconsin–Madison (US)
Corresponding author
Levin, Leonard A.
Venue
Annual Review of Vision Science
Published
2017-09-15
Volume
3
Issue
1
Pages
91-120
ISSN
  • 2374-4642 (ISSN-L)
  • 2374-4650
OpenAlex
W2732996930
Cited by
111
References
185
Citations by year
2026: 7 · 2025: 10 · 2024: 8 · 2023: 19 · 2022: 19 · 2021: 13 · 2020: 18 · 2019: 12 · 2018: 3 · 2017: 2
FWCI
1.77
Type
journal article
Language
en
Open access
Locations
  • Annual Review of Vision Science (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Research to Prevent Blindness
  • Canada Research Chairs
  • National Institutes of Health
  • Canadian Institutes of Health Research
Topics
  • Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
  • Life Sciences › Neuroscience › Neurology › Neurological Disorders and Treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
Keywords
glaucoma, neuroprotection, retinal ganglion cells, optic neuropathy, glaucoma animal model, neuroprotective therapy, intraocular pressure, retinal ganglion cell death, visual field defects
MeSH terms
Neuroprotection, Animals, Disease Models, Animal, Glaucoma, Humans, Optic Nerve Diseases, Neuroprotective Agents, Neurodegenerative Diseases, Laser Therapy, Translational Research, Biomedical

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review